Navigation Links
Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
Date:10/23/2007

CALGARY, Oct. 24 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that a poster presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN(R)/radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented today at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco. The conference runs from October 22-26, 2007.

"We are very encouraged with the results of this trial to date," said Dr. Brad Thompson, President and CEO of Oncolytics. "The data is supportive of our ongoing Phase II REOLYSIN(R)/radiation cotherapy trial in the U.K."

The interim results of the Ia/Ib trial demonstrate that intratumoural treatment with REOLYSIN(R) and radiation is well tolerated and results in both local and remote anti-tumour activity in patients with a variety of advanced cancers. Oncolytics continues to enroll patients in the Ib portion of this trial, and is also actively enrolling patients in a Phase II trial examining this treatment combination.

The presentation, entitled "A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN(R)) in combination with radiation in patients with advanced malignancies" will be delivered by Dr. Dean Harris of The Institute of Cancer Research, London.

These interim results were also presented in early October at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham, U.K.

The poster presentation will be posted on the Oncolytics website today at http://www.oncolyticsbiotech.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. The state of global biotech: An Ernst & Young perspective
2. Olympics of biotechnology has international flavor
3. Biotech officials praise focus of new venture fund
4. Getting noticed in Genetown: Wisconsin biotech on display
5. Madison biotech NimbleGen files for IPO; one of states best-funded firms
6. Wisconsin biotech firm receives $107K NIH grant
7. Biotech executive books a career flight thats closer to home
8. Manufacturing partnership will move into biotech and biomedical spaces
9. Wisconsin wont get Georgia biotech without a fight
10. The 10 biggest events shaping biotech in 2006
11. Gala Biotech among companies sold for $3.3 billion

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... CORDOVA, Calif., Nov. 5 ...upplier of innovative products for processing and ...or the first quarter of fiscal 2010. ,, For the...orted revenues of $5.2 million, a 15 percent incre...rter a year ago. The Company said the key contribu...
(Date:11/5/2009)...ALE, Calif., Nov. 5 Ceph...utives will be speaking at the following investor ...via webcast. , , Credit Suisse Hea...hursday, 12 November, 2009 at 10 a.m. Mountain Tim...am, London, England, Tuesday, 1 De...
(Date:11/5/2009)..., Texas, Nov. 5 SpineSmith Partner...nc. to co-develop a unique scaffold that mimics th... evaluation of several commercial products by Spin...company believes the GenOsteo scaffold represents ...es a unique and ideal environment for the delivery...
(Date:11/5/2009)... Brooke Sanders brings a new look to ...RWEB) November 5, 2009 -- Professional Reprographi...phics company is pleased to present Brooke Sanders... graphics/PR specialist. The addition of Brooke to...rowth within Professional Reprographics., , ,Brook...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...nologies, Inc. (BST), a worldwide provider of long...anagement and cold chain logistics, announces the ... role of Senior Vice President. , , Ball joined B...f Global Sales and Marketing, where she led worldw...ic and international marketing. In her new role, B...
...cs (Alternext:,ALEHT) today announced that 1,076,9...ber 8, 2006 and redeemable November 8, 2011 have b...esults into a EUR 17,231 capital increase and EUR,...At the same time, the,convertible bond debt is red...s of December 31, 2008. , Philippe Rousseau, C...
...tational resources the idea of a computational lab...till faces conceptual and technical challenges. Ch...l reality itself, under conditions of incomplete k...riability and fluctuations. The quantification of ...a collection of scientific ideas into a sub-discip...
Other Biology Technology:BioStorage Technologies, Inc. Promotes Lori Ball to Senior Vice President and Expands Role 2ExonHit Therapeutics Shareholders' Equity Strengthened by Exercise of More Than Half of its Convertible Bonds 2Opportunities and challenges in uncertainty quantification for complex interacting systems 2
(Date:11/8/2009)... Ind. - Researchers at Purdue University have disc...fibers in spinal cord injuries using nano-spheres ...r an accident. , The synthetic "copolymer micell...in diameter, or roughly 100 times smaller than the...e been studying how to deliver drugs for cancer tr...
(Date:11/6/2009)...50th anniversary this month of the publication of ...f Biological Sciences (AIBS) is publishing open ac...in and his historic insights into evolution. , Th...ty of California, Berkeley, and James T. Costa of ...n Myths About Charles Darwin," appeared in the Oct...
(Date:11/5/2009)...iation of Biology Teachers (NABT) will recognize L...ces at Naugatuck Valley Community College (NVCC) i...Education Award during the NABT annual professiona... 2009 in Denver, Colorado. , The Evolution Educa...e of Biological Sciences,(AIBS) and Biological Sc...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 1Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 2Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred 4865 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 1The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 2The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 3The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 4The Blue Foundation for a Healthy Florida Receives Grant to Address National Regional Nursing Shortages 54735 5Laureate Pharma Elects New Board Member 13606 1Laureate Pharma Elects New Board Member 13606 2
... lobster traps in New Hampshire,s Great Bay Estuar...ll. Instead, the University of New Hampshire Ph.D....ters and tracking their migrations year-round. ,...pshire coastline and into Great Bay throughout the... Grant, will provide more accurate information abo...
...University scientists has found for the first time...rth,s ecosystem, rely on the rare trace element mo... to support their wildly productive growth. Most ...th of rainforests comes from tiny bacteria that ca...soil. , Until now, scientists had thought that ph...
...a potential clue to the roots of epilepsy, autism,... While studying the peripheral nerves of the Dros...ric Howlett discovered an unanticipated connection...tter in much of the food we eat and phosphoinosit..., regulates the activity of neurons. , Howlett an...
Other Biology News:UNH researchers track lobster migrations to improve population estimates 2UNH researchers track lobster migrations to improve population estimates 3Princeton-led team finds secret ingredient for the health of tropical rainforests 2Rice University study finds possible clues to epilepsy, autism 2Rice University study finds possible clues to epilepsy, autism 3
Dithiothreitol, 1M from Upstate
BD IMag Anti-Mouse CD90.2 (Thy1.2) Particles-DM 2 x 109 cells from BD Biosciences Pharmingen
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
pRSET-E Echo Expression Vector Kit from Invitrogen
Biology Products: